Enhanced Standard-of-Care for Prevention of COVID-19 Infection
Study Summary
This trial will look at how well tailored counseling and text messaging can help reduce COVID-19 spread after diagnosis. Patients are randomly assigned to one of two groups, with one receiving extra support.
- Prevention of COVID-19 Secondary Infection
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 1 Secondary · Reporting Duration: Baseline & 1-, 6-, 12-, and 24-months post-baseline.
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
Standard-of-Care
1 of 2
Enhanced Standard-of-Care
1 of 2
Active Control
Experimental Treatment
256 Total Participants · 2 Treatment Groups
Primary Treatment: Enhanced Standard-of-Care · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 1 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Are there currently any recruitment opportunities for this research project?
"According to the clinicaltrials.gov database, this medical trial is actively accepting participants as of January 20th, 2023. The study was initially posted on April 11th 2022 and has since been revised multiple times." - Anonymous Online Contributor
What is the total sample size for this research project?
"Correct. According to the data published on clinicaltrials.gov, this medical trial launched on April 11th 2022 is actively looking for participants. 256 individuals are required from a single location, and the information was last updated January 20th 2023." - Anonymous Online Contributor